Results 1 to 10 of about 8,496 (136)

A case of anterior cranial fossa dural arteriovenous fistula concomitant with moyamoya disease [PDF]

Radiology Case Reports
Moyamoya disease is rarely complicated by other cerebrovascular diseases. A man in his 60s presented with subcortical hemorrhage in the left frontal lobe with an anterior cranial fossa dural arteriovenous fistula (dAVF) and concomitant asymptomatic ...
Junki Youda, MD, Tatsuya Shimizu, MD, Ryousuke Shintoku, MD, Masanori Aihara, MD, Masahiko Tosaka, MD, Soichi Oya, MD   +5 more
doaj   +2 more sources

Transcriptomic Profiling Associates Collagen‐Rich Extracellular Matrix With Postoperative Angiogenesis in Moyamoya Disease [PDF]

Journal of Cellular and Molecular Medicine, Volume 30, Issue 16, August 2026.
ABSTRACT Indirect revascularization is an effective treatment for moyamoya disease (MMD), but the surgery effect depends on the collateral vessel formation. This study aimed to explore the molecular mechanisms associated with angiogenesis in the temporal muscle post‐surgery. We employed a single‐centre, prospective sampling, retrospective cohort design.
Jing‐yi Chen, Shun‐fei Xu, Zi‐qing Wang, Wen‐xin Jin, Ri‐sheng Liang, Xian‐kun Tu   +5 more
wiley   +2 more sources

Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report [PDF]

Frontiers in Oncology
Moyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis or occlusion of the terminal portions of the internal carotid arteries and the subsequent development of abnormal compensatory vascular networks.
Yi-ren Cheng, Juan Han, Zi-yi Huang, Ping Qu, Fen Zhou   +4 more
doaj   +2 more sources

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease

Frontiers in Neurology, 2021
Objective: To determine if elevated rates of autoimmune disease are present in children with both Down syndrome and moyamoya disease given the high rates of autoimmune disease reported in both conditions and unknown etiology of angiopathy in this ...
Jonathan D. Santoro, Jonathan D. Santoro, Sarah Lee, Anthony C. Wang, Eugenia Ho, Eugenia Ho, Deepti Nagesh, Deepti Nagesh, Mellad Khoshnood, Runi Tanna, Ramon A. Durazo-Arvizu, Melanie A. Manning, Melanie A. Manning, Brian G. Skotko, Brian G. Skotko, Gary K. Steinberg, Michael S. Rafii, Michael S. Rafii   +17 more
doaj   +1 more source

Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version

Neurologia Medico-Chirurgica, 2022
In this report, we, the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the circle of Willis), describe in detail the changes in the new “Diagnostic Criteria 2021” for moyamoya disease and its scientific basis to make it widely known to ...
Satoshi KURODA, Miki FUJIMURA, Jun TAKAHASHI, Hiroharu KATAOKA, Kuniaki OGASAWARA, Toru IWAMA, Teiji TOMINAGA, Susumu MIYAMOTO, The Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan   +8 more
doaj   +1 more source

Clinical value of the systemic immune-inflammation index in moyamoya disease

Frontiers in Neurology, 2023
BackgroundMoyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune ...
Erheng Liu, Erheng Liu, Chengyuan Liu, Chengyuan Liu, Lide Jin, Hu Zhou, Xueyi Tan, Xueyi Tan, Guibo Zhang, Guibo Zhang, Weihua Tao, Xiang Gao, Heng Zhao, Chao Luo, Xuehua Li, Shuaifeng Yang   +15 more
doaj   +1 more source

Research progress of moyamoya disease combined with renovascular hypertension

Frontiers in Surgery, 2022
Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder.
Erheng Liu, Erheng Liu, Heng Zhao, Chengyuan Liu, Chengyuan Liu, Xueyi Tan, Xueyi Tan, Chao Luo, Chao Luo, Shuaifeng Yang   +9 more
doaj   +1 more source

The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea

BMC Pregnancy and Childbirth, 2022
Background Physiologic changes during pregnancy affect the development of postpartum cerebrovascular disease (CVD) in women with Moyamoya disease. Due to the rare prevalence of Moyamoya disease and its large regional variations, large-scale based studies
Yeonseong Jeong, Yun Ji Jung, Eunjin Noh, Sungyeon Ha, Jeongeun Hwang, Geum Joon Cho, Min-Jeong Oh, Young-Han Kim   +7 more
doaj   +1 more source

Abstract Number ‐ 281: Clinical and Epidemiological Characteristics of Moyamoya Disease Presenting with Concomitant Autoimmune Conditions

Stroke: Vascular and Interventional Neurology, 2023
Introduction Moyamoya disease was first described in the 1950’s. After over six decades, however, the underlying etiology of Moyamoya still remains unknown.
Nolan Brown, Rohin Singh, Daniel Harrison, Megan Bauman, Andreas Seas, Shane Shahrestani, Julian Gendreau, Oren Gottfried   +7 more
doaj   +1 more source

Genetics and Biomarkers of Moyamoya Disease: Significance of as a Susceptibility Gene [PDF]

Journal of Stroke, 2014
Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain.
Miki Fujimura, Shinya Sonobe, Yasuo Nishijima, Kuniyasu Niizuma, Hiroyuki Sakata, Shigeo Kure, Teiji Tominaga   +6 more
doaj   +1 more source